Nearwater Capital Markets’s AbbVie ABBV Stock Holding History

Nearwater Capital Markets’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-125,000	Closed	-$28.9M	–	105
2025 Q3	$28.9M	Hold	125,000	–	–	0.39%	52
2025 Q2	$23.2M	Sell	125,000 -72,000	-37%	-$13.4M	0.37%	50
2025 Q1	$41.3M	Hold	197,000	–	–	1.17%	18
2024 Q4	$35M	Buy	+197,000	New	+$36.2M	1%	27

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Nearwater Capital Markets's ABBV Position: Q4 2025 in Review

Nearwater Capital Markets sold out of AbbVie (ABBV) in Q4 2025, closing a stake of 125,000 shares — an estimated $28.9M sold.

Nearwater Capital Markets first reported a position in ABBV in Q4 2024 and held it in 4 quarters. The position peaked at $41.3M in Q1 2025. 4,146 funds tracked by Wall St. Rank hold ABBV as of Q4 2025.

Nearwater Capital Markets reported no remaining AbbVie position as of Q4 2025 after selling out during the quarter.
Nearwater Capital Markets sold 125,000 AbbVie shares in Q4 2025, an estimated $28.9M.
Nearwater Capital Markets first reported a position in AbbVie in Q4 2024 and held it in 4 quarters.
Nearwater Capital Markets's AbbVie position peaked at $41.3M in Q1 2025.
4,146 funds tracked by Wall St. Rank held AbbVie as of Q4 2025.

Based on Nearwater Capital Markets's 13F filing for Q4 2025, filed 17 Feb 2026.